• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Development of angio-oedema after omalizumab injections in a patient with chronic spontaneous urticaria.

作者信息

Magen E, Chikovani T

机构信息

Medicine C Department, Clinical Immunology and Allergy Unit, Ben Gurion University of Negev, Barzilai University Medical Center, Ashkelon, Israel.

Department of Immunology, Tbilisi State Medical University, Georgia.

出版信息

Clin Exp Dermatol. 2018 Oct;43(7):825. doi: 10.1111/ced.13616. Epub 2018 May 18.

DOI:10.1111/ced.13616
PMID:29777532
Abstract
摘要

相似文献

1
Development of angio-oedema after omalizumab injections in a patient with chronic spontaneous urticaria.一名慢性自发性荨麻疹患者在注射奥马珠单抗后发生血管性水肿。
Clin Exp Dermatol. 2018 Oct;43(7):825. doi: 10.1111/ced.13616. Epub 2018 May 18.
2
Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.奥马珠单抗对 H1 抗组胺药耐药性慢性自发性荨麻疹患者血管性水肿的影响：X-ACT 随机对照试验的结果。
Allergy. 2016 Aug;71(8):1135-44. doi: 10.1111/all.12870. Epub 2016 Mar 31.
3
Angioedema is an unfavorable factor for the response to omalizumab in chronic spontaneous urticaria: A retrospective study.血管性水肿是慢性自发性荨麻疹对奥马珠单抗反应的不利因素：一项回顾性研究。
Dermatol Ther. 2019 Jan;32(1):e12752. doi: 10.1111/dth.12752. Epub 2018 Oct 30.
4
Long-term management of chronic spontaneous urticaria with omalizumab.奥马珠单抗用于慢性自发性荨麻疹的长期管理。
Clin Exp Dermatol. 2017 Oct;42(7):735-742. doi: 10.1111/ced.13173. Epub 2017 Jun 25.
5
Omalizumab-induced triphasic anaphylaxis in a patient with chronic spontaneous urticaria.奥马珠单抗诱发慢性自发性荨麻疹患者的三相过敏反应。
J Eur Acad Dermatol Venereol. 2016 Nov;30(11):e135-e136. doi: 10.1111/jdv.13439. Epub 2015 Oct 7.
6
Effectiveness and safety of omalizumab in a patient with chronic urticaria and hepatitis C.奥马珠单抗在一名慢性荨麻疹合并丙型肝炎患者中的有效性和安全性。
J Eur Acad Dermatol Venereol. 2015 May;29(5):1027-8. doi: 10.1111/jdv.12450. Epub 2014 Mar 14.
7
Adverse Reaction to Omalizumab in Patients with Chronic Urticaria: Flare Up or Ineffectiveness?慢性荨麻疹患者使用奥马珠单抗的不良反应：病情加重还是无效？
Iran J Allergy Asthma Immunol. 2016 Feb;15(1):82-6.
8
Serum sickness-like reaction in a pediatric patient using omalizumab for chronic spontaneous urticaria.一名使用奥马珠单抗治疗慢性自发性荨麻疹的儿科患者出现血清病样反应。
Pediatr Allergy Immunol. 2018 Jun;29(4):449-450. doi: 10.1111/pai.12877. Epub 2018 Apr 15.
9
Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety.奥马珠单抗治疗慢性自发性荨麻疹：疗效与安全性专家综述
Expert Opin Biol Ther. 2017 Mar;17(3):375-385. doi: 10.1080/14712598.2017.1285903. Epub 2017 Feb 9.
10
Successful treatment of occupational delayed pressure urticaria and angioedema with omalizumab.奥马珠单抗成功治疗职业性迟发性压力性荨麻疹和血管性水肿。
Ann Allergy Asthma Immunol. 2016 Jan;116(1):81-2. doi: 10.1016/j.anai.2015.10.009. Epub 2015 Oct 23.

引用本文的文献

1
The Role of Coagulation/Fibrinolysis Biomarkers in Pathophysiology, Disease Severity, and Treatment Response in Patients with Urticaria: A Scoping Review.凝血/纤溶生物标志物在荨麻疹患者病理生理学、疾病严重程度及治疗反应中的作用：一项范围综述
Clin Rev Allergy Immunol. 2025 Mar 10;68(1):25. doi: 10.1007/s12016-025-09036-3.
2
World Workshop on Oral Medicine VII: Oral adverse effects to biologic agents in patients with inflammatory disorders. A scoping review.第七届世界口腔医学研讨会：炎症性疾病患者生物制剂的口腔不良反应。一项范围综述。
J Oral Pathol Med. 2023 Jan;52(1):1-8. doi: 10.1111/jop.13389. Epub 2022 Dec 13.